Exascale Labs Holdings Inc. filed a Form 10-Q with the SEC on November 16, 2026, covering the quarterly period ended September 30, 2026, its first quarterly report following the consummation of a business combination on August 27, 2026.
Key Highlights
- Business Combination closed August 27, 2026: The company disclosed that the transaction was accounted for as a reverse recapitalization, with Exascale Labs Inc. ("Legacy Exascale") identified as the accounting acquirer.
- Share count as of November 16, 2026: The company reported 33,689,050 shares of Class A Common Stock and 30,645,739 shares of Class B Common Stock issued and outstanding, each with a par value of $0.0001 per share.
- Listed securities: Class A Common Stock trades under the symbol XLAB and warrants trade under XLABW, both on The Nasdaq Stock Market LLC.
- Warrant exercise price: Each whole warrant is exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share.
- Company classification: The registrant is identified as a non-accelerated filer, smaller reporting company, and emerging growth company.
- Historical financials restated: Share and per share amounts for periods prior to the August 27, 2026 closing date have been retroactively adjusted to reflect the exchange ratio established in the Business Combination.
Exascale Labs Holdings Reports First Quarter as a Public Company Following Reverse Recapitalization
According to the filing, Exascale Labs Holdings Inc. (NASDAQ:XLAB) completed its Business Combination on August 27, 2026, which the company described as being "accounted for as a reverse recapitalization, with Exascale Labs Inc., a Delaware corporation ('Legacy Exascale'), identified as the accounting acquirer." As a result, the condensed consolidated financial statements included in the report for periods prior to the closing date reflect the financials of Legacy Exascale rather than those of the combined entity.
The company is headquartered at 820 Gessner Road, Suite 332, Houston, TX 77024, and operates in the artificial intelligence infrastructure space, including GPU as a Service ("GaaS") and enterprise AI compute markets, according to the filing's forward-looking statements section. The 10-Q covers the quarterly period ended September 30, 2026, filed on November 16, 2026, under Commission File Number 001-43465.
The filing notes that forward-looking statements contained in the report relate to, among other things, "our expected growth, scale, and market opportunity in artificial intelligence ('AI') infrastructure, GPU as a Service ('GaaS'), and enterprise AI compute markets," and are subject to risks and uncertainties the company identified, including the ability to obtain sufficient additional financing and "our ability to continue as a going concern." The company stated it does not undertake any obligation to update forward-looking statements except as required under applicable securities laws.
What Was Disclosed
Exascale Labs Holdings Inc. filed its first 10-Q following an August 27, 2026 business combination treated as a reverse recapitalization. The filing disclosed share counts, exchange listings, warrant terms, and company classifications as of November 16, 2026.





Please wait processing your request...